Merrimack Pharmaceuticals is an integrated, biopharmaceutical company committed to the innovation of life-enhancing medicines for the treatment of autoimmune disease and cancer. Merrimack is privately held and located in Cambridge, Massachusetts.
June 25, 2009 - Media Alert 'Science Signaling' to Publish Paper on Therapeutically Targeting ErbB3 to Treat Overexpressed or Mutated Oncognes.
April 18 - 22, 2009 Merrimack Pharmaceuticals to Present Multiple Poster Sessions at the American Association of Cancer Research 100th Annual Meeting in Denver, CO.
April 16, 2009 - Media Alert Merrimack Pharmaceuticals to Present Pre-clinical Data on MM-121 and MM-111 at the Annual Meeting of the American Association of Cancer Research.
© 2009 Merrimack Pharmaceuticals
